Sex Differences ID'd in Response to Glioblastoma Treatment

Share this content:
Sex Differences ID'd in Response to Glioblastoma Treatment
Sex Differences ID'd in Response to Glioblastoma Treatment

FRIDAY, Jan. 4, 2019 (HealthDay News) -- Sex differences have been identified in response to therapy among glioblastoma (GBM) patients, according to a study published in the Jan. 2 issue of Science Translational Medicine.

Wei Yang, Ph.D., from the Washington University School of Medicine in St. Louis, and colleagues used a quantitative image-based measure of response to examine the impact of standard therapy on male and female patients with GBM. Data were included for a cohort of 63 patients with GBM (40 male and 23 female patients).

The researchers found that standard therapy was more effective for female versus male patients with GBM. Using a computational algorithm applied to linked GBM transcriptome and outcome data, sex-specific molecular subtypes of GBM were identified; in male and female patients, cell cycle and integrin signaling were identified as critical determinants of survival, respectively. In a panel of male and female patient-derived GBM cell lines, the clinical relevance of cell cycle and integrin signaling pathway signatures was further established.

"It is our expectation that this study could have an immediate impact on the care of patients with glioblastoma and further research, as the findings indicate we should be stratifying male and female glioblastoma into risk groups and evaluating the effectiveness of treatment in a sex-specific manner," a coauthor said in a statement.

One author served as a paid consultant for Monterris and received a Stryker Research Grant.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »